Extranodal disease is associated with shorter progression‐free survival after cd19‐car t‐cell therapy for relapsed/refractory diffuse large b‐cell lymphomaV. Bücklein,V. Blumenberg,J. Ackermann,L. Frölich,M. Winkelmann,C. Schmidt,K. Rejeski,M. Ruzicka,N. Müller,L. von Baumgarten,F. Schöberl,M. Hildebrandt,A. Humpe,W. Kunz,E. Hoster,M. von Bergwelt,M. SubkleweHematological Oncology（2021）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
